Serina Therapeutics, Inc.

SERNYSE· Pharmaceutical Preparations

Price History

Revenue

$56,000

▼ 98.2% YoY

Net Income

-$11.1M

▼ 311.4% YoY

EPS

$-1.51

▼ 306.8% YoY

Cash

$3.7M

▼ 51.8% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.